Jiadai Xu

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Patient Reported

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

OncoTargets and therapy

Leukemia & lymphoma

BioMed research international

Zhongshan Hospital Fudan University Shanghai (Shanghai) (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Zhongshan Hospital Fudan University Shanghai (Shanghai) Sep 01 2017 - Jul 01 2020

China

PHD :: Hematology

Publications

Zhao Xu, Yifeng Sun, Zheng Wei, Jifeng Jiang, Jiadai Xu, Peng Liu
Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia. OncoTargets and therapy 13 (2020)
Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Jing Li, Yuhong Ren, Shiyang Gu, Chen Chen, Zheng Wei, Jingli Zhuang, Zhimei Wang, Lili Ji, Luya Cheng, Weiguang Wang, Zhixiang Cheng, Yang Ke, Ling Yuan, Peng Liu
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides. Leukemia & lymphoma 61 (10) (2020)
Jiadai Xu, Zheng Wei, Yian Zhang, Chen Chen, Jing Li, Peng Liu
A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study. BioMed research international 2018 (2018)